EP2846780
Uppleysanleg hylki með formúluna 1,1-tvímetýl [(1S)-1-{[(2,S,4R)-4-(7-klóró-4metoxýísólkvínólín-1-ýloxý)-2-({(1R,2S)-1-[(sýklóprópýlsúlfónýl)karbamóýl-2-etenýlsýklóprópýl}karbamóýl)prýrrólídón-1-ýl]karbónýl)-2,2-tvíimetýlprópýl]karbamat
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.4.2013EP published:
18.7.2018EP application number:
13722217.0
EP translation filed:
10.8.2018Grant published:
15.9.2018EPO information:
European Patent Register
Max expiry date:
29.4.2033Expiry date:
29.4.2020
Title:
SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
Timeline
Today
30.4.2013EP application
18.7.2018EP Publication
10.8.2018Translation submitted
15.9.2018Registration published
29.4.2020Expires
Owner
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Hinterbergstrasse 16, Steinhausen, CH
Inventor
Name:
PERRONE, Robert KevinAddress:
New Brunswick, New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261643454 PDate:
7.5.2012Country:
US
Classification
Categories:
A61K 9/48, A61K 31/4709, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.3.2019
Expires: 29.4.2020
Payer: Árnason Faktor